×
Hero Background
English
Chinese
French
Japanese
Korean
German
Spanish

Insulin Delivery Devices Market Share

ID: MRFR/HC/0352-CR
200 Pages
Rahul Gotadki
April 2025

Insulin Delivery Devices Market Research Report By Device Type (Insulin Syringes, Insulin Pens, Insulin Pumps, Smart Insulin Devices), By End User (Hospitals, Home Care Settings, Diabetes Clinics), By Product Type (Analogue Insulin Delivery Devices, Pen-Needle Systems, Continuous Glucose Monitoring Systems), By Mode of Delivery (Subcutaneous Injection, Intravenous Injection, Inhaled Insulin) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa)-Forecast to 2035

Share:
Download PDF ×

We do not share your information with anyone. However, we may send you emails based on your report interest from time to time. You may contact us at any time to opt-out.

Insulin Delivery Devices Market Infographic
Request Free Sample
Purchase Options
Compare License
Summary Table of Contents Segmentation Download PDF

Market Share

Insulin Delivery Devices Market Share Analysis

The Insulin Delivery Devices Market is witnessing rapid growth due to the rising prevalence of diabetes worldwide. Key players in this market are strategically implementing various market share positioning strategies to gain a competitive advantage and address the evolving landscape of insulin delivery solutions. Companies are very much putting a lot of fund into innovative business to develop considerably advance insulin delivering devices. It covers the implementation of insulin injectors with smart insulin pens, patch pumps and other technologically advanced devices, which bring about more accurate, effective and easily operated results and integration. It is innovations of distribution systems that gives the edge of your company. Acknowledging the wide range of different requirements and conditions for patients, companies therefore design insulin delivery devices specific to the need of each patient. This approach covers devices with many kinds of designs, interfaces of different types settings which are aimed at the various tastes of patients with diabetes to manage it. Ownership encourage customers to recommend and suggest the product to others. Collaborations with pharma units are a standard practice achieved by market competitors in insulin delivery devices. These connections strive to have insulin delivery means tailored to formulations and medication courses. This integration strengthens the drug regimen and further helps the company's brand name and complete share in the market. The move towards wearable technologies and wearable health remedies is changing the strategies for insulin delivery devices. Companies are innovation an intelligent views to pumps with insulin and devices with connectivity features for remote monitoring and data exchange online. Linkage is one of the major elements that promote better participation of the patients and creates the edge in the market sector. Companies are getting more than just involved in individual education and help programs. These activities gather components like teaching materials, resources, and supports to enable people to do successful insulin that is more effective in delivering the hormone. Education and empower patients to develop and up scale the devices in which case the market will grow.

The growing prevalence of e-commerce has influenced insulin delivery device distribution strategies. Companies are enhancing their online presence and leveraging direct-to-consumer channels. This strategy not only improves product accessibility but also provides a convenient avenue for consumers to purchase insulin delivery devices, contributing to increased market share.

A patient-centric approach is crucial in designing insulin delivery devices. Companies are focusing on ergonomic designs, user-friendly interfaces, and minimizing the overall burden of device management for patients. A patient-centric design enhances user satisfaction and contributes to a positive market perception, leading to increased market share.

Author
Rahul Gotadki
Assistant Manager

He holds an experience of about 7+ years in Market Research and Business Consulting, working under the spectrum of Life Sciences and Healthcare domains. Rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. His expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. In addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives

Get In Touch

Leave a Comment

FAQs

What is the projected market valuation of the Insulin Delivery Devices Market by 2035?

The Insulin Delivery Devices Market is projected to reach a valuation of 26.31 USD Billion by 2035.

What was the market valuation of the Insulin Delivery Devices Market in 2024?

In 2024, the Insulin Delivery Devices Market was valued at 15.14 USD Billion.

What is the expected CAGR for the Insulin Delivery Devices Market during the forecast period 2025 - 2035?

The expected CAGR for the Insulin Delivery Devices Market during the forecast period 2025 - 2035 is 5.15%.

Which company is a key player in the Insulin Delivery Devices Market?

Medtronic, Abbott, and Novo Nordisk are among the key players in the Insulin Delivery Devices Market.

What are the projected revenues for Insulin Pumps by 2035?

The projected revenues for Insulin Pumps are expected to reach between 4.0 and 7.0 USD Billion by 2035.

How much is the Home Care Settings segment expected to generate by 2035?

The Home Care Settings segment is projected to generate between 7.0 and 12.0 USD Billion by 2035.

What is the anticipated revenue for Smart Insulin Devices by 2035?

Smart Insulin Devices are anticipated to generate revenues between 3.14 and 5.31 USD Billion by 2035.

What is the expected revenue range for Continuous Glucose Monitoring Systems by 2035?

Continuous Glucose Monitoring Systems are expected to generate between 4.14 and 8.31 USD Billion by 2035.

What revenue is projected for the Intravenous Injection mode of delivery by 2035?

The Intravenous Injection mode of delivery is projected to generate between 4.0 and 6.0 USD Billion by 2035.

What is the expected revenue for Pen-Needle Systems by 2035?

Pen-Needle Systems are expected to generate revenues between 6.0 and 10.0 USD Billion by 2035.

Market Summary

As per MRFR analysis, the Insulin Delivery Devices Market was estimated at 15.14 USD Billion in 2024. The insulin delivery devices industry is projected to grow from 15.92 USD Billion in 2025 to 26.31 USD Billion by 2035, exhibiting a compound annual growth rate (CAGR) of 5.15% during the forecast period 2025 - 2035.

Key Market Trends & Highlights

The Insulin Delivery Devices Market is experiencing a transformative shift towards advanced technology and personalized care solutions.

  • The integration of smart technology is revolutionizing insulin delivery, enhancing patient monitoring and management. Personalized treatment approaches are gaining traction, allowing for tailored insulin regimens based on individual patient needs. Wearable devices are emerging as a significant trend, providing convenience and real-time data for diabetes management. The rising prevalence of diabetes and technological advancements in delivery systems are key drivers propelling market growth.

Market Size & Forecast

2024 Market Size 15.14 (USD Billion)
2035 Market Size 26.31 (USD Billion)
CAGR (2025 - 2035) 5.15%
Largest Regional Market Share in 2024 North America

Major Players

<p><a href="https://www.medtronic.com/en-us/healthcare-professionals/products.html">Medtronic </a>(US), Abbott (US), Roche (CH), Insulet (US), Novo Nordisk (DK), Sanofi (FR), Boehringer Ingelheim (DE), Ypsomed (CH), <a href="https://www.tandemdiabetes.com/">Tandem Diabetes Care</a> (US)</p>

Market Trends

The Insulin Delivery Devices Market is currently experiencing a transformative phase, driven by advancements in technology and an increasing prevalence of diabetes worldwide. The integration of smart technology into insulin delivery systems appears to enhance patient adherence and improve overall management of diabetes. Moreover, the growing awareness of digital diabetes management options among patients and healthcare providers suggests a shift towards more personalized treatment approaches. This trend may lead to a greater demand for innovative devices that offer convenience and efficiency, thereby reshaping the landscape of diabetes care. In addition, the Insulin Delivery Devices Market seems to be influenced by regulatory changes and the introduction of new products that cater to diverse patient needs. The emergence of wearable devices and automated insulin delivery systems indicates a potential shift towards more user-friendly solutions. As patients seek greater control over their health, the market is likely to witness a surge in demand for devices that not only deliver insulin but also provide real-time data and insights. This evolution in the market landscape underscores the importance of continuous innovation and adaptation to meet the dynamic needs of individuals living with diabetes.

Integration of Smart Technology

The incorporation of smart technology into insulin delivery devices is becoming increasingly prevalent. These devices often feature connectivity options that allow users to monitor their insulin levels and receive alerts, thereby enhancing the management of diabetes.

Personalized Treatment Approaches

There is a noticeable shift towards personalized treatment strategies in the Insulin Delivery Devices Market. Patients are increasingly seeking devices that cater to their specific needs, which may lead to the development of customized solutions.

Emergence of Wearable Devices

Wearable insulin delivery devices are gaining traction, offering users convenience and ease of use. These innovations may provide real-time data and insights, potentially transforming how individuals manage their diabetes.

Insulin Delivery Devices Market Market Drivers

Rising Prevalence of Diabetes

The increasing incidence of diabetes worldwide is a primary driver for the Insulin Delivery Devices Market. According to recent statistics, the number of individuals diagnosed with diabetes is projected to reach approximately 700 million by 2045. This surge in diabetes cases necessitates effective management solutions, thereby propelling the demand for insulin delivery devices. As patients seek more efficient and user-friendly options, manufacturers are innovating to meet these needs. The growing awareness of diabetes management and the importance of insulin therapy further contribute to the expansion of the market. Consequently, the rising prevalence of diabetes is likely to continue influencing the Insulin Delivery Devices Market significantly.

Increased Investment in Diabetes Research

The surge in investment for diabetes research and development is a critical driver for the Insulin Delivery Devices Market. Governments and private organizations are allocating substantial funds to develop innovative solutions for diabetes management. This financial support is fostering advancements in insulin delivery technologies, leading to the introduction of more effective and efficient devices. Furthermore, collaborations between research institutions and manufacturers are becoming more common, facilitating the rapid translation of research findings into market-ready products. As a result, the influx of investment in diabetes research is likely to enhance the growth trajectory of the Insulin Delivery Devices Market.

Growing Demand for Home Healthcare Solutions

The shift towards home healthcare solutions is a notable trend impacting the Insulin Delivery Devices Market. Patients are increasingly opting for at-home management of their diabetes, driven by the desire for convenience and autonomy. This trend has led to a rise in the demand for portable and user-friendly insulin delivery devices that can be used outside clinical settings. Market data suggests that the home healthcare segment is expected to grow significantly, with a projected CAGR of over 10% in the coming years. This growth is indicative of a broader movement towards personalized healthcare, where patients prefer managing their conditions in the comfort of their homes, thereby influencing the Insulin Delivery Devices Market.

Technological Advancements in Delivery Systems

Technological innovations are transforming the Insulin Delivery Devices Market, enhancing the efficacy and convenience of insulin administration. Recent advancements include the development of smart insulin pens, continuous glucose monitors, and automated insulin delivery systems. These devices not only improve patient adherence but also provide real-time data for better glucose management. The integration of mobile applications with insulin delivery devices allows for personalized treatment plans, which is increasingly appealing to patients. As technology continues to evolve, the market is expected to witness a surge in demand for these advanced delivery systems, indicating a promising future for the Insulin Delivery Devices Market.

Rising Awareness and Education on Diabetes Management

The increasing awareness and education surrounding diabetes management are pivotal in shaping the Insulin Delivery Devices Market. Educational initiatives aimed at both healthcare professionals and patients are promoting better understanding of diabetes and the importance of insulin therapy. As awareness grows, patients are more likely to seek out effective insulin delivery solutions, driving market demand. Additionally, healthcare providers are emphasizing the need for proper diabetes management, which includes the use of advanced insulin delivery devices. This heightened focus on education and awareness is expected to contribute positively to the growth of the Insulin Delivery Devices Market.

Market Segment Insights

By Device Type: Insulin Pens (Largest) vs. Insulin Pumps (Fastest-Growing)

<p>The Insulin Delivery Devices Market showcases a distribution where Insulin Pens dominate with the largest market share, attributed to their convenience and widespread adoption among patients. Insulin Syringes maintain a steady presence, primarily utilized in traditional settings, while Smart Insulin Devices, though currently smaller, are gaining traction. Insulin Pumps, once considered niche, have evolved significantly, appealing to more patients with advanced features and personalized delivery.</p>

<p>Insulin Pens (Dominant) vs. Insulin Pumps (Emerging)</p>

<p>Insulin Pens have established themselves as the dominant choice in diabetes management due to their ease of use, accuracy, and portability. These devices cater to a vast demographic, from newly diagnosed patients to long-term users, thanks to their user-friendly design and less intrusive nature. In contrast, Insulin Pumps are emerging as a transformative option for diabetic care, offering continuous insulin delivery and advanced monitoring capabilities. As technology evolves, these pumps are becoming more accessible and appealing, especially among tech-savvy patients looking for customizable treatment options. Both segments play crucial roles, meeting different patient needs and driving innovation in the market.</p>

By End User: Hospitals (Largest) vs. Home Care Settings (Fastest-Growing)

<p>In the Insulin Delivery Devices Market, the end-user segment is primarily driven by hospitals, which hold the largest share due to their extensive usage of insulin delivery systems in managing patient care. Hospitals benefit from having immediate access to healthcare professionals and advanced technologies, facilitating effective diabetes management. In contrast, home care settings are becoming increasingly popular, carving out a significant market share as more individuals opt for self-management of diabetes in the comfort of their homes. This shift is spurred by the increasing prevalence of diabetes and the convenience of at-home care solutions.</p>

<p>Hospitals (Dominant) vs. Home Care Settings (Emerging)</p>

<p>Hospitals hold a dominant position in the insulin delivery devices market as they are fundamental in providing acute and chronic diabetes management for patients. These facilities utilize advanced insulin delivery systems, including insulin pumps and pens, which are critical for managing high blood sugar levels in a timely manner. In comparison, home care settings are emerging as a significant segment due to rising patient autonomy, where individuals increasingly prefer to manage their diabetes at home with user-friendly devices. This transition is driven by technological advancements that enhance ease of use, coupled with the demand for personalized healthcare solutions. The growing awareness and education regarding diabetes management also fuel the adoption of insulin delivery devices in home care environments.</p>

By Product Type: Analogue Insulin Delivery Devices Market (Largest) vs. pen-Needle Systems (Fastest-Growing)

<p>Within the insulin delivery devices market, Analogue Insulin Delivery Devices Market hold the largest market share, appealing to a broad user base seeking more precise and effective diabetes management. This segment has gained traction due to the rise in Type 1 and Type 2 diabetes cases, as well as advances in insulin formulation technology. On the other hand, Pen-Needle Systems, while smaller in market share, are rapidly expanding as they offer increased convenience and reduced pain for patients, which has led to greater adoption and market interest. The continuous evolution of technology in insulin delivery methods has seen Continuous Glucose Monitoring Systems gain momentum, working in conjunction with traditional devices to enhance patient experience. The surge in telemedicine and remote patient monitoring also aids growth, driving innovations in these devices. Factors contributing to the growth include an escalating awareness of diabetes management and lifestyle-related changes that encourage proactive health measures, which will continue to shape market trajectories for the foreseeable future.</p>

<p>Analogue Insulin Delivery Devices Market (Dominant) vs. Continuous Glucose Monitoring Systems (Emerging)</p>

<p>Analogue Insulin Delivery Devices Market remain dominant in the insulin delivery devices market due to their established reputation for efficacy and reliability in managing diabetes. These devices deliver insulin via syringes or pens, which many patients prefer for their familiarity and perceived ease of use. The technological innovations that have accompanied analogue insulins, such as pre-filled pens and improved safety features, contribute to their continued popularity. Conversely, Continuous Glucose Monitoring Systems, while considered emerging, are quickly gaining attention as they provide real-time blood glucose monitoring, enhancing diabetes management strategies. These systems represent a shift towards more integrated healthcare that aligns with the growing trend of personalized medicine, making them attractive to both patients and healthcare providers.</p>

By Mode of Delivery: Subcutaneous Injection (Largest) vs. Inhaled Insulin (Fastest-Growing)

<p>The Insulin Delivery Devices Market showcases a distinct market share distribution among various modes of delivery, with subcutaneous injection leading the sector. This method remains a preferred choice among patients due to its ease of use and effectiveness in managing diabetes. Conversely, inhaled insulin is gaining traction, particularly among younger patients seeking a more convenient alternative. The intravenous injection, while essential in clinical settings, occupies a smaller market share as it is typically reserved for inpatient care. As the market evolves, growth trends indicate a substantial shift towards inhaled insulin as a viable option for users. Rising health awareness, coupled with advancements in technology, is driving the development of more user-friendly devices. Moreover, the convenience factor associated with inhaled insulin is likely to attract new patients, positioning it as a promising segment in the coming years.</p>

<p>Subcutaneous Injection (Dominant) vs. Inhaled Insulin (Emerging)</p>

<p>Subcutaneous injection remains the dominant mode of delivery in the Insulin Delivery Devices Market, largely due to its longstanding familiarity and reliability among diabetes patients. This method is widely recognized for its ability to provide stable insulin levels with minimal discomfort, making it a staple in diabetes management. In contrast, inhaled insulin stands out as an emerging option, appealing to a demographic that prioritizes convenience and ease of use. Patients often prefer inhaled insulin to avoid needles, and innovation in this area is making this delivery method increasingly accessible. As both segments continue to develop, the dynamics between subcutaneous injections and inhaled insulin will shape future market trends and patient preferences.</p>

Get more detailed insights about Insulin Delivery Devices Market Research Report-Forecast to 2035

Regional Insights

The Global Insulin Delivery Devices Market has shown substantial valuations across various regions, reflecting diverse market dynamics. In 2024, the North American region is expected to hold a significant market share valued at 6.0 USD Billion, and it is projected to rise to 10.5 USD Billion by 2035, primarily driven by advanced healthcare infrastructure and increased prevalence of diabetes. Europe follows closely with a valuation of 4.5 USD Billion in 2024, expanding to 7.5 USD Billion in 2035, fueled by growing awareness and adoption of insulin delivery technologies.

The APAC region's market value is 2.5 USD Billion in 2024, anticipated to reach 4.5 USD Billion by 2035, as regional healthcare improvements and rising disposable incomes enhance access to diabetes management solutions. In South America, the market is set at 0.9 USD Billion in 2024 and is estimated to grow to 1.5 USD Billion by 2035, reflecting a gradual increase in healthcare investment. 

Meanwhile, the MEA region, valued at 0.5 USD Billion in 2024, is expected to double to 1.0 USD Billion by 2035, indicating a slow yet steady growth as healthcare infrastructures develop.Each region presents unique growth drivers, challenges, and opportunities, contributing to the overall Global Insulin Delivery Devices Market statistics as it adapts to the increasing global health needs associated with diabetes management.

Key Players and Competitive Insights

The Global Insulin Delivery Devices Market is characterized by a rapidly evolving landscape driven by technological advancements, increasing prevalence of diabetes, and rising awareness about diabetes management. Companies operating in this market are engaged in intense competition, focused on innovation and differentiation to capture market share. The overall aim is to enhance patient compliance, improve glycemic control, and ensure ease of use for consumers. The market harbors several key players, each contributing distinct features to its products while addressing the growing demands for efficiency, performance, and personalized healthcare solutions. 

The competitive environment also emphasizes strategic partnerships, collaborations, and acquisitions among major firms to bolster their positions and expand their product portfolios.Insulet has established a substantial foothold in the Global Insulin Delivery Devices Market, primarily recognized for its innovative Omnipod system, which offers a tubeless insulin delivery solution. This unique approach simplifies the process of insulin administration, contributing to improved patient adherence and satisfaction. 

The company's strengths lie in its advanced technology, commitment to research and development, and focus on user-centric design. Insulet has successfully leveraged partnerships with healthcare providers to enhance the accessibility of its devices, thereby increasing its market share. The strong brand loyalty and positive patient feedback further solidify Insulet's competitive position within the global landscape, enabling it to stand out among other insulin delivery device manufacturers.Roche, a significant player in the Global Insulin Delivery Devices Market, is well-known for its innovative diabetes management solutions, including insulin delivery devices integrated with extensive monitoring systems. 

Roche's strengths are exemplified through its focus on comprehensive diabetes care that resonates with healthcare professionals and patients alike. The company offers a range of insulin delivery systems, such as pens and pumps, paired with precise monitoring solutions that facilitate better glycemic control. Roche has a broad market presence bolstered by strategic mergers and acquisitions that have enabled it to expand its product offerings and enhance its technological capabilities.

This commitment to innovation has allowed Roche to maintain a competitive edge, ensuring that it can cater to the diverse needs of diabetes patients while fostering long-term relationships within the healthcare ecosystem.

Key Companies in the Insulin Delivery Devices Market market include

Industry Developments

The Global Insulin Delivery Devices Market has seen significant developments recently, driven by innovations in technology and a growing demand for diabetes management solutions. In October 2023, Insulet Corporation announced the launch of its new Omnipod 5 insulin delivery system, designed to streamline insulin delivery for patients with Type 1 diabetes. Roche has also made strides with the expansion of its Accu-Chek product line, enhancing connectivity with digital health apps. 

Novo Nordisk reported an increase in market valuation as their new insulin formulations gained market traction, positively impacting their overall financial performance. From a mergers and acquisitions perspective, Johnson and Johnson announced plans in September 2023 to acquire a technology firm specializing in digital therapy solutions, aiming to enhance diabetes care delivery.

Additionally, Eli Lilly secured a partnership with Tandem Diabetes Care earlier this year to integrate their insulin delivery systems with new monitoring technologies, which is expected to enhance patient adherence. Ypsomed has experienced substantial growth driven by rising demand in the Asia-Pacific region, contributing to the robust development in the global landscape. Overall, advancements in automation and connectivity in insulin delivery devices are transforming diabetes management worldwide.

Future Outlook

Insulin Delivery Devices Market Future Outlook

<p>The Insulin Delivery Devices Market is projected to grow at a 5.15% CAGR from 2024 to 2035, driven by technological advancements, increasing diabetes prevalence, and rising patient awareness.</p>

New opportunities lie in:

  • <p>Development of smart insulin pens with integrated digital health features.</p>
  • <p>Expansion of automated insulin delivery systems for improved patient compliance.</p>
  • <p>Partnerships with <a href="https://www.marketresearchfuture.com/reports/telehealth-market-900">telehealth</a> platforms for remote monitoring and support services.</p>

<p>By 2035, the market is expected to be robust, driven by innovation and increased accessibility.</p>

Market Segmentation

Insulin Delivery Devices Market End User Outlook

  • Hospitals
  • Home Care Settings
  • Diabetes Clinics

Insulin Delivery Devices Market Device Type Outlook

  • Insulin Syringes
  • Insulin Pens
  • Insulin Pumps
  • Smart Insulin Devices

Insulin Delivery Devices Market Product Type Outlook

  • Analogue Insulin Delivery Devices
  • Pen-Needle Systems
  • Continuous Glucose Monitoring Systems

Insulin Delivery Devices Market Mode of Delivery Outlook

  • Subcutaneous Injection
  • Intravenous Injection
  • Inhaled Insulin

Report Scope

MARKET SIZE 2024 15.14(USD Billion)
MARKET SIZE 2025 15.92(USD Billion)
MARKET SIZE 2035 26.31(USD Billion)
COMPOUND ANNUAL GROWTH RATE (CAGR) 5.15% (2024 - 2035)
REPORT COVERAGE Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
BASE YEAR 2024
Market Forecast Period 2025 - 2035
Historical Data 2019 - 2024
Market Forecast Units USD Billion
Key Companies Profiled Market analysis in progress
Segments Covered Market segmentation analysis in progress
Key Market Opportunities Integration of smart technology in Insulin Delivery Devices Market enhances patient adherence and management.
Key Market Dynamics Technological advancements and regulatory changes drive innovation and competition in the insulin delivery devices market.
Countries Covered North America, Europe, APAC, South America, MEA

FAQs

What is the projected market valuation of the Insulin Delivery Devices Market by 2035?

The Insulin Delivery Devices Market is projected to reach a valuation of 26.31 USD Billion by 2035.

What was the market valuation of the Insulin Delivery Devices Market in 2024?

In 2024, the Insulin Delivery Devices Market was valued at 15.14 USD Billion.

What is the expected CAGR for the Insulin Delivery Devices Market during the forecast period 2025 - 2035?

The expected CAGR for the Insulin Delivery Devices Market during the forecast period 2025 - 2035 is 5.15%.

Which company is a key player in the Insulin Delivery Devices Market?

Medtronic, Abbott, and Novo Nordisk are among the key players in the Insulin Delivery Devices Market.

What are the projected revenues for Insulin Pumps by 2035?

The projected revenues for Insulin Pumps are expected to reach between 4.0 and 7.0 USD Billion by 2035.

How much is the Home Care Settings segment expected to generate by 2035?

The Home Care Settings segment is projected to generate between 7.0 and 12.0 USD Billion by 2035.

What is the anticipated revenue for Smart Insulin Devices by 2035?

Smart Insulin Devices are anticipated to generate revenues between 3.14 and 5.31 USD Billion by 2035.

What is the expected revenue range for Continuous Glucose Monitoring Systems by 2035?

Continuous Glucose Monitoring Systems are expected to generate between 4.14 and 8.31 USD Billion by 2035.

What revenue is projected for the Intravenous Injection mode of delivery by 2035?

The Intravenous Injection mode of delivery is projected to generate between 4.0 and 6.0 USD Billion by 2035.

What is the expected revenue for Pen-Needle Systems by 2035?

Pen-Needle Systems are expected to generate revenues between 6.0 and 10.0 USD Billion by 2035.

  1. SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
    1. EXECUTIVE SUMMARY
      1. Market Overview
      2. Key Findings
      3. Market Segmentation
      4. Competitive Landscape
      5. Challenges and Opportunities
      6. Future Outlook 2
  2. SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
    1. MARKET INTRODUCTION
      1. Definition
      2. Scope of the study
    2. RESEARCH METHODOLOGY
      1. Overview
      2. Data Mining
      3. Secondary Research
      4. Primary Research
      5. Forecasting Model
      6. Market Size Estimation
      7. Data Triangulation
      8. Validation 3
  3. SECTION III: QUALITATIVE ANALYSIS
    1. MARKET DYNAMICS
      1. Overview
      2. Drivers
      3. Restraints
      4. Opportunities
    2. MARKET FACTOR ANALYSIS
      1. Value chain Analysis
      2. Porter's Five Forces Analysis
      3. COVID-19 Impact Analysis
  4. SECTION IV: QUANTITATIVE ANALYSIS
    1. Healthcare, BY Device Type (USD Billion)
      1. Insulin Syringes
      2. Insulin Pens
      3. Insulin Pumps
      4. Smart Insulin Devices
    2. Healthcare, BY End User (USD Billion)
      1. Hospitals
      2. Home Care Settings
      3. Diabetes Clinics
    3. Healthcare, BY Product Type (USD Billion)
      1. Analogue Insulin Delivery Devices
      2. Pen-Needle Systems
      3. Continuous Glucose Monitoring Systems
    4. Healthcare, BY Mode of Delivery (USD Billion)
      1. Subcutaneous Injection
      2. Intravenous Injection
      3. Inhaled Insulin
    5. Healthcare, BY Region (USD Billion)
      1. North America
      2. Europe
      3. APAC
      4. South America
      5. MEA
  5. SECTION V: COMPETITIVE ANALYSIS
    1. Competitive Landscape
      1. Overview
      2. Competitive Analysis
      3. Market share Analysis
      4. Major Growth Strategy in the Healthcare
      5. Competitive Benchmarking
      6. Leading Players in Terms of Number of Developments in the Healthcare
      7. Key developments and growth strategies
      8. Major Players Financial Matrix
    2. Company Profiles
      1. Medtronic (US)
      2. Abbott (US)
      3. Roche (CH)
      4. Insulet (US)
      5. Novo Nordisk (DK)
      6. Sanofi (FR)
      7. Boehringer Ingelheim (DE)
      8. Ypsomed (CH)
      9. Tandem Diabetes Care (US)
    3. Appendix
      1. References
      2. Related Reports 6 LIST OF FIGURES
    4. MARKET SYNOPSIS
    5. NORTH AMERICA MARKET ANALYSIS
    6. US MARKET ANALYSIS BY DEVICE TYPE
    7. US MARKET ANALYSIS BY END USER
    8. US MARKET ANALYSIS BY PRODUCT TYPE
    9. US MARKET ANALYSIS BY MODE OF DELIVERY
    10. CANADA MARKET ANALYSIS BY DEVICE TYPE
    11. CANADA MARKET ANALYSIS BY END USER
    12. CANADA MARKET ANALYSIS BY PRODUCT TYPE
    13. CANADA MARKET ANALYSIS BY MODE OF DELIVERY
    14. EUROPE MARKET ANALYSIS
    15. GERMANY MARKET ANALYSIS BY DEVICE TYPE
    16. GERMANY MARKET ANALYSIS BY END USER
    17. GERMANY MARKET ANALYSIS BY PRODUCT TYPE
    18. GERMANY MARKET ANALYSIS BY MODE OF DELIVERY
    19. UK MARKET ANALYSIS BY DEVICE TYPE
    20. UK MARKET ANALYSIS BY END USER
    21. UK MARKET ANALYSIS BY PRODUCT TYPE
    22. UK MARKET ANALYSIS BY MODE OF DELIVERY
    23. FRANCE MARKET ANALYSIS BY DEVICE TYPE
    24. FRANCE MARKET ANALYSIS BY END USER
    25. FRANCE MARKET ANALYSIS BY PRODUCT TYPE
    26. FRANCE MARKET ANALYSIS BY MODE OF DELIVERY
    27. RUSSIA MARKET ANALYSIS BY DEVICE TYPE
    28. RUSSIA MARKET ANALYSIS BY END USER
    29. RUSSIA MARKET ANALYSIS BY PRODUCT TYPE
    30. RUSSIA MARKET ANALYSIS BY MODE OF DELIVERY
    31. ITALY MARKET ANALYSIS BY DEVICE TYPE
    32. ITALY MARKET ANALYSIS BY END USER
    33. ITALY MARKET ANALYSIS BY PRODUCT TYPE
    34. ITALY MARKET ANALYSIS BY MODE OF DELIVERY
    35. SPAIN MARKET ANALYSIS BY DEVICE TYPE
    36. SPAIN MARKET ANALYSIS BY END USER
    37. SPAIN MARKET ANALYSIS BY PRODUCT TYPE
    38. SPAIN MARKET ANALYSIS BY MODE OF DELIVERY
    39. REST OF EUROPE MARKET ANALYSIS BY DEVICE TYPE
    40. REST OF EUROPE MARKET ANALYSIS BY END USER
    41. REST OF EUROPE MARKET ANALYSIS BY PRODUCT TYPE
    42. REST OF EUROPE MARKET ANALYSIS BY MODE OF DELIVERY
    43. APAC MARKET ANALYSIS
    44. CHINA MARKET ANALYSIS BY DEVICE TYPE
    45. CHINA MARKET ANALYSIS BY END USER
    46. CHINA MARKET ANALYSIS BY PRODUCT TYPE
    47. CHINA MARKET ANALYSIS BY MODE OF DELIVERY
    48. INDIA MARKET ANALYSIS BY DEVICE TYPE
    49. INDIA MARKET ANALYSIS BY END USER
    50. INDIA MARKET ANALYSIS BY PRODUCT TYPE
    51. INDIA MARKET ANALYSIS BY MODE OF DELIVERY
    52. JAPAN MARKET ANALYSIS BY DEVICE TYPE
    53. JAPAN MARKET ANALYSIS BY END USER
    54. JAPAN MARKET ANALYSIS BY PRODUCT TYPE
    55. JAPAN MARKET ANALYSIS BY MODE OF DELIVERY
    56. SOUTH KOREA MARKET ANALYSIS BY DEVICE TYPE
    57. SOUTH KOREA MARKET ANALYSIS BY END USER
    58. SOUTH KOREA MARKET ANALYSIS BY PRODUCT TYPE
    59. SOUTH KOREA MARKET ANALYSIS BY MODE OF DELIVERY
    60. MALAYSIA MARKET ANALYSIS BY DEVICE TYPE
    61. MALAYSIA MARKET ANALYSIS BY END USER
    62. MALAYSIA MARKET ANALYSIS BY PRODUCT TYPE
    63. MALAYSIA MARKET ANALYSIS BY MODE OF DELIVERY
    64. THAILAND MARKET ANALYSIS BY DEVICE TYPE
    65. THAILAND MARKET ANALYSIS BY END USER
    66. THAILAND MARKET ANALYSIS BY PRODUCT TYPE
    67. THAILAND MARKET ANALYSIS BY MODE OF DELIVERY
    68. INDONESIA MARKET ANALYSIS BY DEVICE TYPE
    69. INDONESIA MARKET ANALYSIS BY END USER
    70. INDONESIA MARKET ANALYSIS BY PRODUCT TYPE
    71. INDONESIA MARKET ANALYSIS BY MODE OF DELIVERY
    72. REST OF APAC MARKET ANALYSIS BY DEVICE TYPE
    73. REST OF APAC MARKET ANALYSIS BY END USER
    74. REST OF APAC MARKET ANALYSIS BY PRODUCT TYPE
    75. REST OF APAC MARKET ANALYSIS BY MODE OF DELIVERY
    76. SOUTH AMERICA MARKET ANALYSIS
    77. BRAZIL MARKET ANALYSIS BY DEVICE TYPE
    78. BRAZIL MARKET ANALYSIS BY END USER
    79. BRAZIL MARKET ANALYSIS BY PRODUCT TYPE
    80. BRAZIL MARKET ANALYSIS BY MODE OF DELIVERY
    81. MEXICO MARKET ANALYSIS BY DEVICE TYPE
    82. MEXICO MARKET ANALYSIS BY END USER
    83. MEXICO MARKET ANALYSIS BY PRODUCT TYPE
    84. MEXICO MARKET ANALYSIS BY MODE OF DELIVERY
    85. ARGENTINA MARKET ANALYSIS BY DEVICE TYPE
    86. ARGENTINA MARKET ANALYSIS BY END USER
    87. ARGENTINA MARKET ANALYSIS BY PRODUCT TYPE
    88. ARGENTINA MARKET ANALYSIS BY MODE OF DELIVERY
    89. REST OF SOUTH AMERICA MARKET ANALYSIS BY DEVICE TYPE
    90. REST OF SOUTH AMERICA MARKET ANALYSIS BY END USER
    91. REST OF SOUTH AMERICA MARKET ANALYSIS BY PRODUCT TYPE
    92. REST OF SOUTH AMERICA MARKET ANALYSIS BY MODE OF DELIVERY
    93. MEA MARKET ANALYSIS
    94. GCC COUNTRIES MARKET ANALYSIS BY DEVICE TYPE
    95. GCC COUNTRIES MARKET ANALYSIS BY END USER
    96. GCC COUNTRIES MARKET ANALYSIS BY PRODUCT TYPE
    97. GCC COUNTRIES MARKET ANALYSIS BY MODE OF DELIVERY
    98. SOUTH AFRICA MARKET ANALYSIS BY DEVICE TYPE
    99. SOUTH AFRICA MARKET ANALYSIS BY END USER
    100. SOUTH AFRICA MARKET ANALYSIS BY PRODUCT TYPE
    101. SOUTH AFRICA MARKET ANALYSIS BY MODE OF DELIVERY
    102. REST OF MEA MARKET ANALYSIS BY DEVICE TYPE
    103. REST OF MEA MARKET ANALYSIS BY END USER
    104. REST OF MEA MARKET ANALYSIS BY PRODUCT TYPE
    105. REST OF MEA MARKET ANALYSIS BY MODE OF DELIVERY
    106. KEY BUYING CRITERIA OF HEALTHCARE
    107. RESEARCH PROCESS OF MRFR
    108. DRO ANALYSIS OF HEALTHCARE
    109. DRIVERS IMPACT ANALYSIS: HEALTHCARE
    110. RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
    111. SUPPLY / VALUE CHAIN: HEALTHCARE
    112. HEALTHCARE, BY DEVICE TYPE, 2024 (% SHARE)
    113. HEALTHCARE, BY DEVICE TYPE, 2024 TO 2035 (USD Billion)
    114. HEALTHCARE, BY END USER, 2024 (% SHARE)
    115. HEALTHCARE, BY END USER, 2024 TO 2035 (USD Billion)
    116. HEALTHCARE, BY PRODUCT TYPE, 2024 (% SHARE)
    117. HEALTHCARE, BY PRODUCT TYPE, 2024 TO 2035 (USD Billion)
    118. HEALTHCARE, BY MODE OF DELIVERY, 2024 (% SHARE)
    119. HEALTHCARE, BY MODE OF DELIVERY, 2024 TO 2035 (USD Billion)
    120. BENCHMARKING OF MAJOR COMPETITORS 7 LIST OF TABLES
    121. LIST OF ASSUMPTIONS
    122. North America MARKET SIZE ESTIMATES; FORECAST
      1. BY DEVICE TYPE, 2025-2035 (USD Billion)
      2. BY END USER, 2025-2035 (USD Billion)
      3. BY PRODUCT TYPE, 2025-2035 (USD Billion)
      4. BY MODE OF DELIVERY, 2025-2035 (USD Billion)
    123. US MARKET SIZE ESTIMATES; FORECAST
      1. BY DEVICE TYPE, 2025-2035 (USD Billion)
      2. BY END USER, 2025-2035 (USD Billion)
      3. BY PRODUCT TYPE, 2025-2035 (USD Billion)
      4. BY MODE OF DELIVERY, 2025-2035 (USD Billion)
    124. Canada MARKET SIZE ESTIMATES; FORECAST
      1. BY DEVICE TYPE, 2025-2035 (USD Billion)
      2. BY END USER, 2025-2035 (USD Billion)
      3. BY PRODUCT TYPE, 2025-2035 (USD Billion)
      4. BY MODE OF DELIVERY, 2025-2035 (USD Billion)
    125. Europe MARKET SIZE ESTIMATES; FORECAST
      1. BY DEVICE TYPE, 2025-2035 (USD Billion)
      2. BY END USER, 2025-2035 (USD Billion)
      3. BY PRODUCT TYPE, 2025-2035 (USD Billion)
      4. BY MODE OF DELIVERY, 2025-2035 (USD Billion)
    126. Germany MARKET SIZE ESTIMATES; FORECAST
      1. BY DEVICE TYPE, 2025-2035 (USD Billion)
      2. BY END USER, 2025-2035 (USD Billion)
      3. BY PRODUCT TYPE, 2025-2035 (USD Billion)
      4. BY MODE OF DELIVERY, 2025-2035 (USD Billion)
    127. UK MARKET SIZE ESTIMATES; FORECAST
      1. BY DEVICE TYPE, 2025-2035 (USD Billion)
      2. BY END USER, 2025-2035 (USD Billion)
      3. BY PRODUCT TYPE, 2025-2035 (USD Billion)
      4. BY MODE OF DELIVERY, 2025-2035 (USD Billion)
    128. France MARKET SIZE ESTIMATES; FORECAST
      1. BY DEVICE TYPE, 2025-2035 (USD Billion)
      2. BY END USER, 2025-2035 (USD Billion)
      3. BY PRODUCT TYPE, 2025-2035 (USD Billion)
      4. BY MODE OF DELIVERY, 2025-2035 (USD Billion)
    129. Russia MARKET SIZE ESTIMATES; FORECAST
      1. BY DEVICE TYPE, 2025-2035 (USD Billion)
      2. BY END USER, 2025-2035 (USD Billion)
      3. BY PRODUCT TYPE, 2025-2035 (USD Billion)
      4. BY MODE OF DELIVERY, 2025-2035 (USD Billion)
    130. Italy MARKET SIZE ESTIMATES; FORECAST
      1. BY DEVICE TYPE, 2025-2035 (USD Billion)
      2. BY END USER, 2025-2035 (USD Billion)
      3. BY PRODUCT TYPE, 2025-2035 (USD Billion)
      4. BY MODE OF DELIVERY, 2025-2035 (USD Billion)
    131. Spain MARKET SIZE ESTIMATES; FORECAST
      1. BY DEVICE TYPE, 2025-2035 (USD Billion)
      2. BY END USER, 2025-2035 (USD Billion)
      3. BY PRODUCT TYPE, 2025-2035 (USD Billion)
      4. BY MODE OF DELIVERY, 2025-2035 (USD Billion)
    132. Rest of Europe MARKET SIZE ESTIMATES; FORECAST
      1. BY DEVICE TYPE, 2025-2035 (USD Billion)
      2. BY END USER, 2025-2035 (USD Billion)
      3. BY PRODUCT TYPE, 2025-2035 (USD Billion)
      4. BY MODE OF DELIVERY, 2025-2035 (USD Billion)
    133. APAC MARKET SIZE ESTIMATES; FORECAST
      1. BY DEVICE TYPE, 2025-2035 (USD Billion)
      2. BY END USER, 2025-2035 (USD Billion)
      3. BY PRODUCT TYPE, 2025-2035 (USD Billion)
      4. BY MODE OF DELIVERY, 2025-2035 (USD Billion)
    134. China MARKET SIZE ESTIMATES; FORECAST
      1. BY DEVICE TYPE, 2025-2035 (USD Billion)
      2. BY END USER, 2025-2035 (USD Billion)
      3. BY PRODUCT TYPE, 2025-2035 (USD Billion)
      4. BY MODE OF DELIVERY, 2025-2035 (USD Billion)
    135. India MARKET SIZE ESTIMATES; FORECAST
      1. BY DEVICE TYPE, 2025-2035 (USD Billion)
      2. BY END USER, 2025-2035 (USD Billion)
      3. BY PRODUCT TYPE, 2025-2035 (USD Billion)
      4. BY MODE OF DELIVERY, 2025-2035 (USD Billion)
    136. Japan MARKET SIZE ESTIMATES; FORECAST
      1. BY DEVICE TYPE, 2025-2035 (USD Billion)
      2. BY END USER, 2025-2035 (USD Billion)
      3. BY PRODUCT TYPE, 2025-2035 (USD Billion)
      4. BY MODE OF DELIVERY, 2025-2035 (USD Billion)
    137. South Korea MARKET SIZE ESTIMATES; FORECAST
      1. BY DEVICE TYPE, 2025-2035 (USD Billion)
      2. BY END USER, 2025-2035 (USD Billion)
      3. BY PRODUCT TYPE, 2025-2035 (USD Billion)
      4. BY MODE OF DELIVERY, 2025-2035 (USD Billion)
    138. Malaysia MARKET SIZE ESTIMATES; FORECAST
      1. BY DEVICE TYPE, 2025-2035 (USD Billion)
      2. BY END USER, 2025-2035 (USD Billion)
      3. BY PRODUCT TYPE, 2025-2035 (USD Billion)
      4. BY MODE OF DELIVERY, 2025-2035 (USD Billion)
    139. Thailand MARKET SIZE ESTIMATES; FORECAST
      1. BY DEVICE TYPE, 2025-2035 (USD Billion)
      2. BY END USER, 2025-2035 (USD Billion)
      3. BY PRODUCT TYPE, 2025-2035 (USD Billion)
      4. BY MODE OF DELIVERY, 2025-2035 (USD Billion)
    140. Indonesia MARKET SIZE ESTIMATES; FORECAST
      1. BY DEVICE TYPE, 2025-2035 (USD Billion)
      2. BY END USER, 2025-2035 (USD Billion)
      3. BY PRODUCT TYPE, 2025-2035 (USD Billion)
      4. BY MODE OF DELIVERY, 2025-2035 (USD Billion)
    141. Rest of APAC MARKET SIZE ESTIMATES; FORECAST
      1. BY DEVICE TYPE, 2025-2035 (USD Billion)
      2. BY END USER, 2025-2035 (USD Billion)
      3. BY PRODUCT TYPE, 2025-2035 (USD Billion)
      4. BY MODE OF DELIVERY, 2025-2035 (USD Billion)
    142. South America MARKET SIZE ESTIMATES; FORECAST
      1. BY DEVICE TYPE, 2025-2035 (USD Billion)
      2. BY END USER, 2025-2035 (USD Billion)
      3. BY PRODUCT TYPE, 2025-2035 (USD Billion)
      4. BY MODE OF DELIVERY, 2025-2035 (USD Billion)
    143. Brazil MARKET SIZE ESTIMATES; FORECAST
      1. BY DEVICE TYPE, 2025-2035 (USD Billion)
      2. BY END USER, 2025-2035 (USD Billion)
      3. BY PRODUCT TYPE, 2025-2035 (USD Billion)
      4. BY MODE OF DELIVERY, 2025-2035 (USD Billion)
    144. Mexico MARKET SIZE ESTIMATES; FORECAST
      1. BY DEVICE TYPE, 2025-2035 (USD Billion)
      2. BY END USER, 2025-2035 (USD Billion)
      3. BY PRODUCT TYPE, 2025-2035 (USD Billion)
      4. BY MODE OF DELIVERY, 2025-2035 (USD Billion)
    145. Argentina MARKET SIZE ESTIMATES; FORECAST
      1. BY DEVICE TYPE, 2025-2035 (USD Billion)
      2. BY END USER, 2025-2035 (USD Billion)
      3. BY PRODUCT TYPE, 2025-2035 (USD Billion)
      4. BY MODE OF DELIVERY, 2025-2035 (USD Billion)
    146. Rest of South America MARKET SIZE ESTIMATES; FORECAST
      1. BY DEVICE TYPE, 2025-2035 (USD Billion)
      2. BY END USER, 2025-2035 (USD Billion)
      3. BY PRODUCT TYPE, 2025-2035 (USD Billion)
      4. BY MODE OF DELIVERY, 2025-2035 (USD Billion)
    147. MEA MARKET SIZE ESTIMATES; FORECAST
      1. BY DEVICE TYPE, 2025-2035 (USD Billion)
      2. BY END USER, 2025-2035 (USD Billion)
      3. BY PRODUCT TYPE, 2025-2035 (USD Billion)
      4. BY MODE OF DELIVERY, 2025-2035 (USD Billion)
    148. GCC Countries MARKET SIZE ESTIMATES; FORECAST
      1. BY DEVICE TYPE, 2025-2035 (USD Billion)
      2. BY END USER, 2025-2035 (USD Billion)
      3. BY PRODUCT TYPE, 2025-2035 (USD Billion)
      4. BY MODE OF DELIVERY, 2025-2035 (USD Billion)
    149. South Africa MARKET SIZE ESTIMATES; FORECAST
      1. BY DEVICE TYPE, 2025-2035 (USD Billion)
      2. BY END USER, 2025-2035 (USD Billion)
      3. BY PRODUCT TYPE, 2025-2035 (USD Billion)
      4. BY MODE OF DELIVERY, 2025-2035 (USD Billion)
    150. Rest of MEA MARKET SIZE ESTIMATES; FORECAST
      1. BY DEVICE TYPE, 2025-2035 (USD Billion)
      2. BY END USER, 2025-2035 (USD Billion)
      3. BY PRODUCT TYPE, 2025-2035 (USD Billion)
      4. BY MODE OF DELIVERY, 2025-2035 (USD Billion)
    151. PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
    152. ACQUISITION/PARTNERSHIP

Insulin Delivery Devices Market Segmentation

Insulin Delivery Devices Market By Device Type (USD Billion, 2019-2035)

Insulin Syringes

Insulin Pens

Insulin Pumps

Smart Insulin Devices

Insulin Delivery Devices Market By End User (USD Billion, 2019-2035)

Hospitals

Home Care Settings

Diabetes Clinics

Insulin Delivery Devices Market By Product Type (USD Billion, 2019-2035)

Analogue Insulin Delivery Devices

Pen-Needle Systems

Continuous Glucose Monitoring System

Insulin Delivery Devices Market By Mode of Delivery (USD Billion, 2019-2035)

Subcutaneous Injection

Intravenous Injection

Inhaled Insulin

Insulin Delivery Devices Market By Regional (USD Billion, 2019-2035)

North America

Europe

South America

Asia Pacific

Middle East and Africa

Insulin Delivery Devices Market Regional Outlook (USD Billion, 2019-2035)

North America Outlook (USD Billion, 2019-2035)

North America Insulin Delivery Devices Market by Device Type

Insulin Syringes

Insulin Pens

Insulin Pumps

Smart Insulin Devices

North America Insulin Delivery Devices Market by End User Type

Hospitals

Home Care Settings

Diabetes Clinics

North America Insulin Delivery Devices Market by Product Type

Analogue Insulin Delivery Devices

Pen-Needle Systems

Continuous Glucose Monitoring Systems

North America Insulin Delivery Devices Market by Mode of Delivery Type

Subcutaneous Injection

Intravenous Injection

Inhaled Insulin

North America Insulin Delivery Devices Market by Regional Type

US

Canada

US Outlook (USD Billion, 2019-2035)

US Insulin Delivery Devices Market by Device Type

Insulin Syringes

Insulin Pens

Insulin Pumps

Smart Insulin Devices

US Insulin Delivery Devices Market by End User Type

Hospitals

Home Care Settings

Diabetes Clinics

US Insulin Delivery Devices Market by Product Type

Analogue Insulin Delivery Devices

Pen-Needle Systems

Continuous Glucose Monitoring Systems

US Insulin Delivery Devices Market by Mode of Delivery Type

Subcutaneous Injection

Intravenous Injection

Inhaled Insulin

CANADA Outlook (USD Billion, 2019-2035)

CANADA Insulin Delivery Devices Market by Device Type

Insulin Syringes

Insulin Pens

Insulin Pumps

Smart Insulin Devices

CANADA Insulin Delivery Devices Market by End User Type

Hospitals

Home Care Settings

Diabetes Clinics

CANADA Insulin Delivery Devices Market by Product Type

Analogue Insulin Delivery Devices

Pen-Needle Systems

Continuous Glucose Monitoring Systems

CANADA Insulin Delivery Devices Market by Mode of Delivery Type

Subcutaneous Injection

Intravenous Injection

Inhaled Insulin

Europe Outlook (USD Billion, 2019-2035)

Europe Insulin Delivery Devices Market by Device Type

Insulin Syringes

Insulin Pens

Insulin Pumps

Smart Insulin Devices

Europe Insulin Delivery Devices Market by End User Type

Hospitals

Home Care Settings

Diabetes Clinics

Europe Insulin Delivery Devices Market by Product Type

Analogue Insulin Delivery Devices

Pen-Needle Systems

Continuous Glucose Monitoring Systems

Europe Insulin Delivery Devices Market by Mode of Delivery Type

Subcutaneous Injection

Intravenous Injection

Inhaled Insulin

Europe Insulin Delivery Devices Market by Regional Type

Germany

UK

France

Russia

Italy

Spain

Rest of Europe

GERMANY Outlook (USD Billion, 2019-2035)

GERMANY Insulin Delivery Devices Market by Device Type

Insulin Syringes

Insulin Pens

Insulin Pumps

Smart Insulin Devices

GERMANY Insulin Delivery Devices Market by End User Type

Hospitals

Home Care Settings

Diabetes Clinics

GERMANY Insulin Delivery Devices Market by Product Type

Analogue Insulin Delivery Devices

Pen-Needle Systems

Continuous Glucose Monitoring Systems

GERMANY Insulin Delivery Devices Market by Mode of Delivery Type

Subcutaneous Injection

Intravenous Injection

Inhaled Insulin

UK Outlook (USD Billion, 2019-2035)

UK Insulin Delivery Devices Market by Device Type

Insulin Syringes

Insulin Pens

Insulin Pumps

Smart Insulin Devices

UK Insulin Delivery Devices Market by End User Type

Hospitals

Home Care Settings

Diabetes Clinics

UK Insulin Delivery Devices Market by Product Type

Analogue Insulin Delivery Devices

Pen-Needle Systems

Continuous Glucose Monitoring Systems

UK Insulin Delivery Devices Market by Mode of Delivery Type

Subcutaneous Injection

Intravenous Injection

Inhaled Insulin

FRANCE Outlook (USD Billion, 2019-2035)

FRANCE Insulin Delivery Devices Market by Device Type

Insulin Syringes

Insulin Pens

Insulin Pumps

Smart Insulin Devices

FRANCE Insulin Delivery Devices Market by End User Type

Hospitals

Home Care Settings

Diabetes Clinics

FRANCE Insulin Delivery Devices Market by Product Type

Analogue Insulin Delivery Devices

Pen-Needle Systems

Continuous Glucose Monitoring Systems

FRANCE Insulin Delivery Devices Market by Mode of Delivery Type

Subcutaneous Injection

Intravenous Injection

Inhaled Insulin

RUSSIA Outlook (USD Billion, 2019-2035)

RUSSIA Insulin Delivery Devices Market by Device Type

Insulin Syringes

Insulin Pens

Insulin Pumps

Smart Insulin Devices

RUSSIA Insulin Delivery Devices Market by End User Type

Hospitals

Home Care Settings

Diabetes Clinics

RUSSIA Insulin Delivery Devices Market by Product Type

Analogue Insulin Delivery Devices

Pen-Needle Systems

Continuous Glucose Monitoring Systems

RUSSIA Insulin Delivery Devices Market by Mode of Delivery Type

Subcutaneous Injection

Intravenous Injection

Inhaled Insulin

ITALY Outlook (USD Billion, 2019-2035)

ITALY Insulin Delivery Devices Market by Device Type

Insulin Syringes

Insulin Pens

Insulin Pumps

Smart Insulin Devices

ITALY Insulin Delivery Devices Market by End User Type

Hospitals

Home Care Settings

Diabetes Clinics

ITALY Insulin Delivery Devices Market by Product Type

Analogue Insulin Delivery Devices

Pen-Needle Systems

Continuous Glucose Monitoring Systems

ITALY Insulin Delivery Devices Market by Mode of Delivery Type

Subcutaneous Injection

Intravenous Injection

Inhaled Insulin

SPAIN Outlook (USD Billion, 2019-2035)

SPAIN Insulin Delivery Devices Market by Device Type

Insulin Syringes

Insulin Pens

Insulin Pumps

Smart Insulin Devices

SPAIN Insulin Delivery Devices Market by End User Type

Hospitals

Home Care Settings

Diabetes Clinics

SPAIN Insulin Delivery Devices Market by Product Type

Analogue Insulin Delivery Devices

Pen-Needle Systems

Continuous Glucose Monitoring Systems

SPAIN Insulin Delivery Devices Market by Mode of Delivery Type

Subcutaneous Injection

Intravenous Injection

Inhaled Insulin

REST OF EUROPE Outlook (USD Billion, 2019-2035)

REST OF EUROPE Insulin Delivery Devices Market by Device Type

Insulin Syringes

Insulin Pens

Insulin Pumps

Smart Insulin Devices

REST OF EUROPE Insulin Delivery Devices Market by End User Type

Hospitals

Home Care Settings

Diabetes Clinics

REST OF EUROPE Insulin Delivery Devices Market by Product Type

Analogue Insulin Delivery Devices

Pen-Needle Systems

Continuous Glucose Monitoring Systems

REST OF EUROPE Insulin Delivery Devices Market by Mode of Delivery Type

Subcutaneous Injection

Intravenous Injection

Inhaled Insulin

APAC Outlook (USD Billion, 2019-2035)

APAC Insulin Delivery Devices Market by Device Type

Insulin Syringes

Insulin Pens

Insulin Pumps

Smart Insulin Devices

APAC Insulin Delivery Devices Market by End User Type

Hospitals

Home Care Settings

Diabetes Clinics

APAC Insulin Delivery Devices Market by Product Type

Analogue Insulin Delivery Devices

Pen-Needle Systems

Continuous Glucose Monitoring Systems

APAC Insulin Delivery Devices Market by Mode of Delivery Type

Subcutaneous Injection

Intravenous Injection

Inhaled Insulin

APAC Insulin Delivery Devices Market by Regional Type

China

India

Japan

South Korea

Malaysia

Thailand

Indonesia

Rest of APAC

CHINA Outlook (USD Billion, 2019-2035)

CHINA Insulin Delivery Devices Market by Device Type

Insulin Syringes

Insulin Pens

Insulin Pumps

Smart Insulin Devices

CHINA Insulin Delivery Devices Market by End User Type

Hospitals

Home Care Settings

Diabetes Clinics

CHINA Insulin Delivery Devices Market by Product Type

Analogue Insulin Delivery Devices

Pen-Needle Systems

Continuous Glucose Monitoring Systems

CHINA Insulin Delivery Devices Market by Mode of Delivery Type

Subcutaneous Injection

Intravenous Injection

Inhaled Insulin

INDIA Outlook (USD Billion, 2019-2035)

INDIA Insulin Delivery Devices Market by Device Type

Insulin Syringes

Insulin Pens

Insulin Pumps

Smart Insulin Devices

INDIA Insulin Delivery Devices Market by End User Type

Hospitals

Home Care Settings

Diabetes Clinics

INDIA Insulin Delivery Devices Market by Product Type

Analogue Insulin Delivery Devices

Pen-Needle Systems

Continuous Glucose Monitoring Systems

INDIA Insulin Delivery Devices Market by Mode of Delivery Type

Subcutaneous Injection

Intravenous Injection

Inhaled Insulin

JAPAN Outlook (USD Billion, 2019-2035)

JAPAN Insulin Delivery Devices Market by Device Type

Insulin Syringes

Insulin Pens

Insulin Pumps

Smart Insulin Devices

JAPAN Insulin Delivery Devices Market by End User Type

Hospitals

Home Care Settings

Diabetes Clinics

JAPAN Insulin Delivery Devices Market by Product Type

Analogue Insulin Delivery Devices

Pen-Needle Systems

Continuous Glucose Monitoring Systems

JAPAN Insulin Delivery Devices Market by Mode of Delivery Type

Subcutaneous Injection

Intravenous Injection

Inhaled Insulin

SOUTH KOREA Outlook (USD Billion, 2019-2035)

SOUTH KOREA Insulin Delivery Devices Market by Device Type

Insulin Syringes

Insulin Pens

Insulin Pumps

Smart Insulin Devices

SOUTH KOREA Insulin Delivery Devices Market by End User Type

Hospitals

Home Care Settings

Diabetes Clinics

SOUTH KOREA Insulin Delivery Devices Market by Product Type

Analogue Insulin Delivery Devices

Pen-Needle Systems

Continuous Glucose Monitoring Systems

SOUTH KOREA Insulin Delivery Devices Market by Mode of Delivery Type

Subcutaneous Injection

Intravenous Injection

Inhaled Insulin

MALAYSIA Outlook (USD Billion, 2019-2035)

MALAYSIA Insulin Delivery Devices Market by Device Type

Insulin Syringes

Insulin Pens

Insulin Pumps

Smart Insulin Devices

MALAYSIA Insulin Delivery Devices Market by End User Type

Hospitals

Home Care Settings

Diabetes Clinics

MALAYSIA Insulin Delivery Devices Market by Product Type

Analogue Insulin Delivery Devices

Pen-Needle Systems

Continuous Glucose Monitoring Systems

MALAYSIA Insulin Delivery Devices Market by Mode of Delivery Type

Subcutaneous Injection

Intravenous Injection

Inhaled Insulin

THAILAND Outlook (USD Billion, 2019-2035)

THAILAND Insulin Delivery Devices Market by Device Type

Insulin Syringes

Insulin Pens

Insulin Pumps

Smart Insulin Devices

THAILAND Insulin Delivery Devices Market by End User Type

Hospitals

Home Care Settings

Diabetes Clinics

THAILAND Insulin Delivery Devices Market by Product Type

Analogue Insulin Delivery Devices

Pen-Needle Systems

Continuous Glucose Monitoring Systems

THAILAND Insulin Delivery Devices Market by Mode of Delivery Type

Subcutaneous Injection

Intravenous Injection

Inhaled Insulin

INDONESIA Outlook (USD Billion, 2019-2035)

INDONESIA Insulin Delivery Devices Market by Device Type

Insulin Syringes

Insulin Pens

Insulin Pumps

Smart Insulin Devices

INDONESIA Insulin Delivery Devices Market by End User Type

Hospitals

Home Care Settings

Diabetes Clinics

INDONESIA Insulin Delivery Devices Market by Product Type

Analogue Insulin Delivery Devices

Pen-Needle Systems

Continuous Glucose Monitoring Systems

INDONESIA Insulin Delivery Devices Market by Mode of Delivery Type

Subcutaneous Injection

Intravenous Injection

Inhaled Insulin

REST OF APAC Outlook (USD Billion, 2019-2035)

REST OF APAC Insulin Delivery Devices Market by Device Type

Insulin Syringes

Insulin Pens

Insulin Pumps

Smart Insulin Devices

REST OF APAC Insulin Delivery Devices Market by End User Type

Hospitals

Home Care Settings

Diabetes Clinics

REST OF APAC Insulin Delivery Devices Market by Product Type

Analogue Insulin Delivery Devices

Pen-Needle Systems

Continuous Glucose Monitoring Systems

REST OF APAC Insulin Delivery Devices Market by Mode of Delivery Type

Subcutaneous Injection

Intravenous Injection

Inhaled Insulin

South America Outlook (USD Billion, 2019-2035)

South America Insulin Delivery Devices Market by Device Type

Insulin Syringes

Insulin Pens

Insulin Pumps

Smart Insulin Devices

South America Insulin Delivery Devices Market by End User Type

Hospitals

Home Care Settings

Diabetes Clinics

South America Insulin Delivery Devices Market by Product Type

Analogue Insulin Delivery Devices

Pen-Needle Systems

Continuous Glucose Monitoring Systems

South America Insulin Delivery Devices Market by Mode of Delivery Type

Subcutaneous Injection

Intravenous Injection

Inhaled Insulin

South America Insulin Delivery Devices Market by Regional Type

Brazil

Mexico

Argentina

Rest of South America

BRAZIL Outlook (USD Billion, 2019-2035)

BRAZIL Insulin Delivery Devices Market by Device Type

Insulin Syringes

Insulin Pens

Insulin Pumps

Smart Insulin Devices

BRAZIL Insulin Delivery Devices Market by End User Type

Hospitals

Home Care Settings

Diabetes Clinics

BRAZIL Insulin Delivery Devices Market by Product Type

Analogue Insulin Delivery Devices

Pen-Needle Systems

Continuous Glucose Monitoring Systems

BRAZIL Insulin Delivery Devices Market by Mode of Delivery Type

Subcutaneous Injection

Intravenous Injection

Inhaled Insulin

MEXICO Outlook (USD Billion, 2019-2035)

MEXICO Insulin Delivery Devices Market by Device Type

Insulin Syringes

Insulin Pens

Insulin Pumps

Smart Insulin Devices

MEXICO Insulin Delivery Devices Market by End User Type

Hospitals

Home Care Settings

Diabetes Clinics

MEXICO Insulin Delivery Devices Market by Product Type

Analogue Insulin Delivery Devices

Pen-Needle Systems

Continuous Glucose Monitoring Systems

MEXICO Insulin Delivery Devices Market by Mode of Delivery Type

Subcutaneous Injection

Intravenous Injection

Inhaled Insulin

ARGENTINA Outlook (USD Billion, 2019-2035)

ARGENTINA Insulin Delivery Devices Market by Device Type

Insulin Syringes

Insulin Pens

Insulin Pumps

Smart Insulin Devices

ARGENTINA Insulin Delivery Devices Market by End User Type

Hospitals

Home Care Settings

Diabetes Clinics

ARGENTINA Insulin Delivery Devices Market by Product Type

Analogue Insulin Delivery Devices

Pen-Needle Systems

Continuous Glucose Monitoring Systems

ARGENTINA Insulin Delivery Devices Market by Mode of Delivery Type

Subcutaneous Injection

Intravenous Injection

Inhaled Insulin

REST OF SOUTH AMERICA Outlook (USD Billion, 2019-2035)

REST OF SOUTH AMERICA Insulin Delivery Devices Market by Device Type

Insulin Syringes

Insulin Pens

Insulin Pumps

Smart Insulin Devices

REST OF SOUTH AMERICA Insulin Delivery Devices Market by End User Type

Hospitals

Home Care Settings

Diabetes Clinics

REST OF SOUTH AMERICA Insulin Delivery Devices Market by Product Type

Analogue Insulin Delivery Devices

Pen-Needle Systems

Continuous Glucose Monitoring Systems

REST OF SOUTH AMERICA Insulin Delivery Devices Market by Mode of Delivery Type

Subcutaneous Injection

Intravenous Injection

Inhaled Insulin

MEA Outlook (USD Billion, 2019-2035)

MEA Insulin Delivery Devices Market by Device Type

Insulin Syringes

Insulin Pens

Insulin Pumps

Smart Insulin Devices

MEA Insulin Delivery Devices Market by End User Type

Hospitals

Home Care Settings

Diabetes Clinics

MEA Insulin Delivery Devices Market by Product Type

Analogue Insulin Delivery Devices

Pen-Needle Systems

Continuous Glucose Monitoring Systems

MEA Insulin Delivery Devices Market by Mode of Delivery Type

Subcutaneous Injection

Intravenous Injection

Inhaled Insulin

MEA Insulin Delivery Devices Market by Regional Type

GCC Countries

South Africa

Rest of MEA

GCC COUNTRIES Outlook (USD Billion, 2019-2035)

GCC COUNTRIES Insulin Delivery Devices Market by Device Type

Insulin Syringes

Insulin Pens

Insulin Pumps

Smart Insulin Devices

GCC COUNTRIES Insulin Delivery Devices Market by End User Type

Hospitals

Home Care Settings

Diabetes Clinics

GCC COUNTRIES Insulin Delivery Devices Market by Product Type

Analogue Insulin Delivery Devices

Pen-Needle Systems

Continuous Glucose Monitoring Systems

GCC COUNTRIES Insulin Delivery Devices Market by Mode of Delivery Type

Subcutaneous Injection

Intravenous Injection

Inhaled Insulin

SOUTH AFRICA Outlook (USD Billion, 2019-2035)

SOUTH AFRICA Insulin Delivery Devices Market by Device Type

Insulin Syringes

Insulin Pens

Insulin Pumps

Smart Insulin Devices

SOUTH AFRICA Insulin Delivery Devices Market by End User Type

Hospitals

Home Care Settings

Diabetes Clinics

SOUTH AFRICA Insulin Delivery Devices Market by Product Type

Analogue Insulin Delivery Devices

Pen-Needle Systems

Continuous Glucose Monitoring Systems

SOUTH AFRICA Insulin Delivery Devices Market by Mode of Delivery Type

Subcutaneous Injection

Intravenous Injection

Inhaled Insulin

REST OF MEA Outlook (USD Billion, 2019-2035)

REST OF MEA Insulin Delivery Devices Market by Device Type

Insulin Syringes

Insulin Pens

Insulin Pumps

Smart Insulin Devices

REST OF MEA Insulin Delivery Devices Market by End User Type

Hospitals

Home Care Settings

Diabetes Clinics

REST OF MEA Insulin Delivery Devices Market by Product Type

Analogue Insulin Delivery Devices

Pen-Needle Systems

Continuous Glucose Monitoring Systems

REST OF MEA Insulin Delivery Devices Market by Mode of Delivery Type

Subcutaneous Injection

Intravenous Injection

Inhaled Insulin

Infographic

Free Sample Request

Kindly complete the form below to receive a free sample of this Report

Get Free Sample

Related Reports

Regional Reports
Country Reports

Customer Strories

Customer Stories
Case Study
Aerospace & Defense
Future of Dismounted Soldier Systems Market Trends & Adoption Roadmap 2019–2035

Compare Licence

×
Features License Type
Single User Multiuser License Enterprise User
Price $4,950 $5,950 $7,250
Maximum User Access Limit 1 User Upto 10 Users Unrestricted Access Throughout the Organization
Free Customization ✓ ✓ ✓
Direct Access to Analyst ✓ ✓ ✓
Deliverable Format ✓ ✓ ✓
Platform Access ✗ ✗ ✓
Discount on Next Purchase 10% 15% 15%
Printable Versions ✗ ✗ ✓